SCI Abstract

search
Machine learning in the prevention of heart failure
Machine learning in the prevention of heart failure
Heart failure (HF) is a global pandemic with a growing prevalence and is a growing burden on the healthcare system. Machin...
The chronobiology of human heart failure: clinical implications and therapeutic opportunities
The chronobiology of human heart failure: clinical implications and therapeutic opportunities
Circadian variation in cardiovascular and metabolic dynamics arises from interactions between intrinsic rhythms and extrin...
Dietary sodium intake restriction in patients with heart failure: an overview of systematic reviews
Dietary sodium intake restriction in patients with heart failure: an overview of systematic reviews
This study aimed to identify, assess, and summarize systematic reviews on dietary sodium intake restrictions for patients ...
In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure
In-hospital initiation of sodium-glucose co-transporter-2 inhibitors in patients with acute heart failure
Sodium-glucose cotransporter-2 (SGLT2) inhibitors provide cardiovascular and kidney benefits to patients with heart failur...
Heart failure with reduced ejection fraction and chronic kidney disease: a focus on therapies and interventions
Heart failure with reduced ejection fraction and chronic kidney disease: a focus on therapies and interventions
In heart failure with reduced ejection fraction (HFrEF), the presence of concomitant chronic kidney disease (CKD) predicts...
Adrenal crisis-induced cardiogenic shock (ACCS): a comprehensive review
Adrenal crisis-induced cardiogenic shock (ACCS): a comprehensive review
Adrenal insufficiency (AI) is a disorder in which inadequate glucocorticoid and mineralocorticoid hormone production leads...
Contextualizing the results of HELIOS-B in the broader landscape of clinical trials for the treatment of transthyretin cardiac amyloidosis
Contextualizing the results of HELIOS-B in the broader landscape of clinical trials for the treatment of transthyretin cardiac amyloidosis
This focused review will highlight the results of HELIOS-B, the first randomized outcomes trial evaluating a gene silencin...
The sympathetic nervous system in heart failure with preserved ejection fraction
The sympathetic nervous system in heart failure with preserved ejection fraction
The sympathetic nervous system (SNS) is a major mediator of cardiovascular physiology during exercise in healthy people. H...
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction (HFpEF) represents a significant challenge in modern cardiovascular medicin...
Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCM
Modulating energy metabolism to treat non-obstructive hypertrophic cardiomyopathy? Insights from IMPROVE-HCM
Hypertrophic cardiomyopathy (HCM) is the most common genetic heart disease worldwide and may present with or without dynam...
The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy
The many faces of SCN5A pathogenic variants: from channelopathy to cardiomyopathy
The SCN5A gene encodes the alpha subunit of the cardiac sodium channel, which plays a fundamental role in the generation a...
Changing the paradigm in heart failure: shifting from treatment to prevention
Changing the paradigm in heart failure: shifting from treatment to prevention
Heart failure (HF) poses a major global health challenge with rising prevalence, significant morbidity and mortality, and ...
Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction
Beyond weight loss: the potential of glucagon-like peptide-1 receptor agonists for treating heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with various phenotypes, and obesity is...
BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis
BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: A systematic review and meta-analysis
Heart failure with preserved ejection fraction (HFpEF) presents a challenge in clinical practice due to its complexity and...
The role of coronary microcirculation in heart failure with preserved ejection fraction: An unceasing odyssey
The role of coronary microcirculation in heart failure with preserved ejection fraction: An unceasing odyssey
Heart failure with preserved ejection fraction (HFpEF) represents an entity with complex pathophysiologic pathways, among ...
National outcomes for dementia patients undergoing cardiac surgery in a pre-structural era
National outcomes for dementia patients undergoing cardiac surgery in a pre-structural era
With an aging population and higher prevalence of dementia, there is a paucity of data regarding dementia patients undergo...
Feasibility of epicardial implantation of medtronic 3830 lead in a pediatric patient : case report
Feasibility of epicardial implantation of medtronic 3830 lead in a pediatric patient : case report
High-grade atrioventricular block is the primary reason for epicardial permanent pacemaker implantation during the periope...
Early surgery to prevent embolic events in patients with infective endocarditis: a comprehensive review
Early surgery to prevent embolic events in patients with infective endocarditis: a comprehensive review
Infective endocarditis (IE) is a dangerous and lethal illness with high mortality rates. One of the main indications for s...
KM04416 suppressed lung adenocarcinoma progression by promoting immune infiltration
KM04416 suppressed lung adenocarcinoma progression by promoting immune infiltration
Lung adenocarcinoma (LUAD) is a malignant tumor originating from the bronchial mucosa or glands of the lung, with the fast...
Budget impact analyses for treatment of heart failure. A systematic review
Budget impact analyses for treatment of heart failure. A systematic review
Heart failure (HF) is increasing globally and turning out to be a serious worldwide public health problem with significant...
Abnormal phosphorylation / dephosphorylation and Ca2+ dysfunction in heart failure
Abnormal phosphorylation / dephosphorylation and Ca2+ dysfunction in heart failure
Heart failure (HF) can be caused by a variety of causes characterized by abnormal myocardial systole and diastole. Ca2+ cu...
New perspectives in the echocardiographic hemodynamics multiparametric assessment of patients with heart failure
New perspectives in the echocardiographic hemodynamics multiparametric assessment of patients with heart failure
International Guidelines consider left ventricular ejection fraction (LVEF) as an important parameter to categorize patien...